Fibrinolysis Concept

subject area of

• 6 Mechanism of action of the thrombolytic agents  Academic Article
• A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin–antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen  Academic Article
• A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits.  Academic Article
• A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism  Academic Article
• A critical review of the relationship between impaired fibrinolysis and myocardial infarction  Academic Article
• A randomized, controlled trial of the effects of rosiglitazone on adipokines, and inflammatory and fibrinolytic markers in diabetic patients: Study design and protocol  Academic Article
• Accelerated Infusion of Streptokinase for the Treatment of Left-Sided Prosthetic Valve Thrombosis  Academic Article
• Action of Gold Sodium Thiomalate on Experimental Thrombosis In Vivo  Academic Article
• Addition of a sequence from α2-antiplasmin transforms human serum albumin into a blood clot component that speeds clot lysis  Academic Article
• Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis.  Academic Article
• Altered preoperative coagulation and fibrinolysis are associated with myocardial injury after non-cardiac surgery  Academic Article
• Anticoagulant therapy with ancrod  Academic Article
• Approaches to investigating common bleeding disorders: An evaluation of North American coagulation laboratory practices  Academic Article
• Aspirin and fibrinolysis in acute myocardial infarction: Meta-analytic evidence for synergy  Academic Article
• Assessment of effectiveness of major bleeding management: proposed definitions for effective hemostasis: communication from the SSC of the ISTH  Academic Article
• BACKGROUND VARIABLES (MEDICAL HISTORY, ANTHROPOMETRIC AND BIOLOGICAL FACTORS) IN RELATION TO THE OUTCOME OF LUMBAR DISC SURGERY  Academic Article
• Blood tests for the diagnosis of venous and arterial thrombosis.  Academic Article
• Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis  Academic Article
• Coagulation and Fibrinolytic Profile of Paediatric Patients Undergoing Cardiopulmonary Bypass  Academic Article
• Coagulation disorders of cardiopulmonary bypass: a review  Academic Article
• Coagulation factor XIII and markers of thrombin generation and fibrinolysis in patients with inflammatory bowel disease  Academic Article
• DDAVP—The Multipotent Drug in Patients With Coagulopathies  Academic Article
• Development of an assay for in vivo human neutrophil elastase activity. Increased elastase activity in patients with alpha 1-proteinase inhibitor deficiency.  Academic Article
• Development of the hemostatic system in the neonate and young infant.  Academic Article
• Diagnosis and Management of Mild Bleeding Disorders  Academic Article
• Does an enzyme other than thrombin contribute to unexpected changes in the levels of the different forms of thrombin activatable fibrinolysis inhibitor in patients with hemophilia A, hemophilia B and von Willebrand disease?  Academic Article
• Dosage Regimens for Streptokinase Treatment: Evaluation of a Standard Dosage Schedule  Academic Article
• EXPERIMENTAL PRODUCTION OF MICROANGIOPATHIC HÆMOLYTIC ANÆMIA IN VIVO  Academic Article
• Effect of activation of the fibrinolytic mechanism on experimental platelet-rich thrombi in rabbits.  Academic Article
• Effect of ascorbate on fibrinolytic factors in septic mouse skeletal muscle  Academic Article
• Effect of gaboon viper (Bitis gabonica) venom on blood coagulation, platelets, and the fibrinolytic enzyme system  Academic Article
• Effect of streptokinase therapy on experimental fibrin-rich arterial thrombi.  Academic Article
• Efficacy of early invasive management post-fibrinolysis in men versus women with ST-elevation myocardial infarction: A subgroup analysis from Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI)  Academic Article
• EspP, an Extracellular Serine Protease from Enterohemorrhagic E. coli, Reduces Coagulation Factor Activities, Reduces Clot Strength, and Promotes Clot Lysis  Academic Article
• Evaluation of and recommendation for the nomenclature of theCPB2gene product (also known as TAFI and proCPU): communication from the SSC of the ISTH  Academic Article
• Evidence that postoperative fibrinolytic shutdown is mediated by plasma factors that stimulate endothelial cell type I plasminogen activator inhibitor biosynthesis.  Academic Article
• FIBRIN CLOT LYSIS BY TISSUE PLASMINOGEN ACTIVATOR (tPA) IS IMPAIRED IN PLASMA FROM PEDIATRIC PATIENTS UNDERGOING ORTHOTOPIC LIVER TRANSPLANTATION  Academic Article
• FIBRINOLYTICAL ACTIVITY IN RELATION TO PSYCHOLOGICAL TRAITS IN PATIENTS WITH SCIATICA  Academic Article
• Factors and inhibitors of blood coagulation and fibrinolysis in acute nonlymphoblastic leukaemia  Academic Article
• Fibrinogen Catabolism in Microangiopathic Haemolytic Anaemia  Academic Article
• Fibrinogen proteolysis and platelet alpha-granule release in preeclampsia/eclampsia.  Academic Article
• Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. The Coagulation Project Investigators of the Bolus Alteplase Pulmonary Embolism Group.  Academic Article
• Fibrinolysis in coronary artery surgery: detection by thromboelastography  Academic Article
• Fibrinolysis, inhibitors of blood coagulation, and monocyte derived coagulant activity in acute malaria  Academic Article
• Fibrinolytic Poly(dimethyl siloxane) Surfaces  Academic Article
• Fibrinolytic System in Adolescents: Response to Venous Occlusion Stress Tests  Academic Article
• Fibrinolytic Variables in Patients with Recurrent Venous Thrombosis: a Prospective Cohort Study  Academic Article
• Fibrinolytic properties of lysine-derivatized polyethylene in contact with flowing whole blood (Chandler loop model)  Academic Article
• Fibrinolytic response to venous occlusion is decreased in patients after Kawasaki disease  Academic Article
• Further thoughts on the importance of models in the assessment of clinical evidence  Academic Article
• Heparin compromises streptokinase-induced arterial patency in rabbits  Academic Article
• Hypercoagulability.  Academic Article
• Impact of Arterial Procedures on Coagulation and Fibrinolysis – A Pilot Study  Academic Article
• Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus  Academic Article
• Impaired Fibrinolytic Activity Is Present in Children with Dyslipidemias  Academic Article
• Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type1 diabetic patients  Academic Article
• In-Vitro Studies with Ancrod (‘Arvin’)  Academic Article
• Incorporation of Fragment X into Fibrin Clots Renders Them More Susceptible to Lysis by Plasmin†  Academic Article
• Increases in factor VIII complex and fibrinolytic activity are dependent on exercise intensity  Academic Article
• Influence of Fibrinolytic Factors on Scar Formation After Lumbar Discectomy  Academic Article
• Influence of changes in lifestyle on fibrinolytic parameters and recurrence rate in patients with venous thromboembolism  Academic Article
• Insights into thrombin activatable fibrinolysis inhibitor function and regulation  Academic Article
• Interactions of fibrinolytic system proteins with lysine-containing surfaces  Academic Article
• Interactions of heparin and a covalently-linked antithrombin-heparin complex with components of the fibrinolytic system  Academic Article
• Intracellular activation of the fibrinolytic cascade in the Quebec Platelet Disorder  Academic Article
• Investigation of the Mechanism of False Positive125I-Labelled Fibrinogen Scans  Academic Article
• Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity  Academic Article
• Leukocyte urokinase plasminogen activator receptor and PSGL1 play a role in endogenous arterial fibrinolysis  Academic Article
• Limited Fibrin Specificity of Tissue-type Plasminogen Activator and Its Potential Link to Bleeding  Academic Article
• Lys 42/43/44 and Arg 12 of thrombin-activable fibrinolysis inhibitor comprise a thrombomodulin exosite essential for its antifibrinolytic potential  Academic Article
• Lysine–poly(2-hydroxyethyl methacrylate) modified polyurethane surface with high lysine density and fibrinolytic activity  Academic Article
• Mechanism of transient adsorption of fibrinogen from plasma to solid surfaces: role of the contact and fibrinolytic systems.  Academic Article
• Microangiopathic Haemolytic Anaemia: the Experimental Production of Haemolysis and Red-Cell Fragmentation by Defibrination in Vivo  Academic Article
• New Anticoagulant Drugs  Academic Article
• New Concepts in Coagulation  Academic Article
• Pathophysiologic and therapeutic importance of tissue ACE: a consensus report.  Academic Article
• Pharmacologic tools to reduce bleeding in surgery.  Academic Article
• Plasma Urokinase Antigen and Plasminogen Activator Inhibitor-1 Antigen Levels Predict Angiographic Coronary Restenosis  Academic Article
• Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator  Academic Article
• Polymorphic Variation of Genes in the Fibrinolytic System and the Risk of Ovarian Cancer  Academic Article
• Prevention of Venous Thromboembolism  Academic Article
• Proceedings: Platelet survival, fibrinolytic activity, antithrombin II (AT III) level and fibrinogen survival in venous thromboembolism (VTE).  Academic Article
• Protein-Resistant and Fibrinolytic Polyurethane Surfaces  Academic Article
• Quebec platelet disorder: features, pathogenesis and treatment  Academic Article
• RELEVANCE OF PREOPERATIVE AND POSTOPERATIVE BLOOD TESTS TO POSTOPERATIVE LEG-VEIN THROMBOSIS  Academic Article
• Reduced Plasminogen Binding and Delayed Activation Render γ′-Fibrin More Resistant to Lysis than γA-Fibrin  Academic Article
• Relationship of Metabolic Syndrome and Fibrinolytic Dysfunction to Cardiovascular Disease  Academic Article
• Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.  Academic Article
• Streptokinase in acute major pulmonary embolism.  Academic Article
• Surfaces having dual fibrinolytic and protein resistant properties by immobilization of lysine on polyurethane through a PEG spacer  Academic Article
• Sustained thrombolysis with DNA-recombinant tissue type plasminogen activator in rabbits.  Academic Article
• TAFIa (CPU) is generatedin vivoat levels that can substantially affect fibrinolysis in chimpanzees in response to thrombin generation  Academic Article
• THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION.  Academic Article
• The Coagulation System in Humans  Academic Article
• The Effects of Hormone Replacement Therapy on Thrombin Generation, Fibrinolysis Inhibition, and Resistance to Activated Protein C  Academic Article
• The Effects of Steroids on Coagulation Dysfunction Induced by Cardiopulmonary Bypass: A Steroids in Cardiac Surgery (SIRS) Trial Substudy  Academic Article
• The diagnosis and prevention of post operative venous thrombosis.  Academic Article
• The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trial  Academic Article
• The fibrinolytic system in newborns and children.  Academic Article
• The impact of the endothelial protein C receptor on thrombin generation and clot lysis  Academic Article
• The onerous task of comparing treatments in inhibitor patients  Academic Article
• The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Duration of Anticoagulation (DURAC) Trial Study Group.  Academic Article
• The thrombolytic and hemorrhagic effects of tissue type plasminogen activator: Influence of dosage regimens in rabrits  Academic Article
• Theoretical and Practical Aspects of Thrombolytic Therapy  Academic Article
• Thrombolysis and fibrinolytic parameters during heparin treatment of deep vein thrombosis  Academic Article
• Thrombolysis by chemically modified coagulation factor Xa  Academic Article
• Thrombosis in children with malignancy  Academic Article
• Tissue plasminogen activator-containing polyurethane surfaces for fibrinolytic activity  Academic Article
• Treatment of acute ischemic stroke: from fibrinolysis to neurointervention  Academic Article
• Treatment of venous thromboembolic disease.  Academic Article
• Urokinase Therapy: Dosage Schedules and Coagulant Side Effects  Academic Article
• Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation  Academic Article
• Zinc promotes clot stability by accelerating clot formation and modifying fibrin structure  Academic Article
• Zinc: An important cofactor in haemostasis and thrombosis  Academic Article
• [Pathogenesis of thrombosis].  Academic Article